参考文献 References
[1] 阿纳尔, 贾国荣. 多发性骨髓瘤中表观遗传学修饰的研究进展[J]. 现代肿瘤医学, 2022,30(21):4000-4004.
[2] 袁杰, 申娴娟, 景蓉蓉, 等. 多发性骨髓瘤相关信号通路与miRNA相互调控的研究进展[J]. 临床检验杂志, 2015, 33(09):698-702.
[3] Zhang J, Luo C, Long H, et al. Circulating exosomal miRNA-451 as an effective diagnostic biomarker and prognostic indicator for multiple myeloma[J]. Int J Biol Markers, 2024,39(4):301-309.
[4] Roseth Aass K, Nedal T M V, Anshushaug Bouma S, et al. Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival[J]. Br J Cancer, 2023,128(4):656-664.
[5] Liu X, Qin L, Li W, et al. MicroRNA-1179 targets Epiregulin (EREG) regulates the proliferation and metastasis of human multiple myeloma cells[J]. Acta Biochim Pol, 2023,70(2):389-393.
[6] Liu Z, Han M, Meng N, et al. lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma[J]. Oxid Med Cell Longev, 2021,2021:9969449.
[7] Zhang H, Du Z, Tu C, et al. Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma[J]. Cancer Res, 2024,84(1):39-55.
[8] Liu W, Wang X, Zhang X, et al. Shear stress-mediated downregulation of miR-423-5p in M2 macrophage exosomes promotes osteogenic differentiation of bone marrow mesenchymal stem cells[J]. Int Immunopharmacol, 2025,164:115298.
[9] Bamfield-Cummings S, Silva J, Karim Z A. A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma[J]. SAGE Open Med, 2025,13: 352787994.
[10] Zhang Z, Li Y, Geng C, et al. Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma[J]. Biomed Res Int, 2019,2019:1575468.
[11] Moura S R, Abreu H, Cunha C, et al. Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions[J]. Cancers (Basel), 2021,13(21).
[12] Chen H, Cao W, Chen J, et al. miR-218 contributes to drug resistance in multiple myeloma via targeting LRRC28[J]. J Cell Biochem, 2021,122(3-4):305-314.
[13] Pula A, Robak P, Robak T. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance[J]. Curr Med Chem, 2021,28(33):6753-6772.
[14] Xu L, Xie Z, Jiang H, et al. Identification and evaluation of a six-lncRNA prognostic signature for multiple myeloma[J]. Discov Oncol, 2024,15(1):204.
[15] Papanota A, Karousi P, Kontos C K, et al. Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background[J]. Int J Mol Sci, 2021,22(5).
[16] Wu Z, Zhang Y, Yang Z, et al. Elevation of miR-302b prevents multiple myeloma cell growth and bone destruction by blocking DKK1 secretion[J]. Cancer Cell Int, 2021,21(1):187.
[17] Soliman A M, Lin T S, Mahakkanukrauh P, et al. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma[J]. Int J Mol Sci, 2020,21(20).
[18] Raimondo S, Urzi O, Conigliaro A, et al. Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma[J]. Cancers (Basel), 2020,12(2).
[19] Soliman A M, Das S, Teoh S L. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis[J]. Int J Mol Sci, 2021,22(14).